by Massimo Filippi
Neurodegeneration in Multiple Sclerosis conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment.
Neurodegeneration in Multiple Sclerosis features:
- Alzheimer’s disease
- Expanded Disability Status Scale
- brain
- magnetization trasfer ratio
- normal-appearing grey matter
Contents
- Neuropathological Advances in Multiple Sclerosis
- Neurophysiology.- MRI Techniques to Assess Neurodegeneration
- Atrophy
- T1 Black Holes and Gray Matter Damage
- Magnetization Transfer Imaging
- Perfusion MRI
- Diffusion-Weighted Imaging
- Proton MR Spectroscopy
- Functional MRI.-Evaluation of MRI Outcomes
- Validation of MRI Surrogates
- Defining Responders and Non-responders
- Predictive Models in Multimodal Imaging.- Lessons from other Neurodegenerative Diseases
- Alzheimer’s Disease
- Other Neurodegenerative Conditions
- Incorporation of Other Biomarkers.- Designing MS Trials for Neurodegeneration
- Critical Review of Existing Trials
- Design for the Next Trials of Neurodegeneration
Index